4-aminopyrazolo(3,4-d)pyrimidine has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HENDERSON, JF; JUNGA, IG | 2 |
| Bell, RL; Bouska, J; Davidsen, SK; Hu, X; Hubbard, RD; Johnson, EF; Kovar, P; Mantei, RA; Osterling, DJ; Sheppard, GS; Tucker, L; Wang, GT; Wang, J; Wilsbacher, JL; Zhang, Q | 1 |
3 other study(ies) available for 4-aminopyrazolo(3,4-d)pyrimidine and Neoplasms
| Article | Year |
|---|---|
Effects of 4-aminopyrazolo (3,4-d)pyrimidine and 1-methyl-4-aminopyrazolo(3,4-d)pyrimidine on nucleic acid purine metabolism in ascites tumors.
Topics: Adenine; Ascites; Neoplasms; Nucleic Acids; Purines; Pyrimidines | 1961 |
The metabolism of 4-aminopyrazolo(3,4-d)pyrimidine in normal and neoplastic tissues.
Topics: Adenine; Neoplasms; Pyrimidines | 1961 |
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases.
Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Mice; Mice, Inbred C57BL; Neoplasms; Rats; Receptor, ErbB-2; Receptor, IGF Type 1; Structure-Activity Relationship | 2010 |